Passage Bio Inc (NASDAQ: PASG) is -41.81% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $1.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PASG stock was last observed hovering at around $0.33 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.33, the stock is -15.31% and -26.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 0.30% at the moment leaves the stock -48.79% off its SMA200. PASG registered -73.39% loss for a year compared to 6-month loss of -43.20%. The firm has a 50-day simple moving average (SMA 50) of $0.44992 and a 200-day simple moving average (SMA200) of $0.64435.
The stock witnessed a -29.03% gain in the last 1 month and extending the period to 3 months gives it a -45.00%, and is -8.81% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.90% over the week and 15.22% over the month.
Passage Bio Inc (PASG) has around 60 employees, a market worth around $20.51M and $0.00M in sales. Distance from 52-week low is 10.00% and -79.88% from its 52-week high. The company has generated returns on investments over the last 12 months (-77.99%).
The EPS is expected to grow by 34.77% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
55.0 institutions hold shares in Passage Bio Inc (PASG), with institutional investors hold 60.93% of the company’s shares. The shares outstanding are 62.06M, and float is at 52.23M with Short Float at 3.35%. Institutions hold 60.63% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 10.12 million shares valued at $8.04 million. The investor’s holdings represent 17.9847 of the PASG Shares outstanding. As of 2024-06-30, the second largest holder is VESTAL POINT CAPITAL, LP with 6.05 million shares valued at $4.81 million to account for 10.7504 of the shares outstanding. The other top investors are LYNX1 CAPITAL MANAGEMENT LP which holds 5.06 million shares representing 8.9841 and valued at over $4.02 million, while VERSANT VENTURE MANAGEMENT, LLC holds 7.1523 of the shares totaling 4.03 million with a market value of $3.2 million.
Passage Bio Inc (PASG) Insider Activity
The most recent transaction is an insider sale by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC sold 77,090 shares of the company’s common stock on Apr 17 ’25 at a price of $0.33 per share for a total of $25440.0. Following the sale, the insider now owns 6.89 million shares.
Passage Bio Inc disclosed in a document filed with the SEC on Apr 16 ’25 that ORBIMED ADVISORS LLC (10% Owner) sold a total of 61,638 shares of the company’s common stock. The trade occurred on Apr 16 ’25 and was made at $0.33 per share for $20341.0. Following the transaction, the insider now directly holds 6.96 million shares of the PASG stock.
Still, SEC filings show that on Apr 15 ’25, ORBIMED ADVISORS LLC (10% Owner) disposed off 10,326 shares at an average price of $0.38 for $3924.0. The insider now directly holds 7,024,300 shares of Passage Bio Inc (PASG).
